Partnership will educate on body contouring options and encourage consumers to “Shape Your Moment” with CoolSculpting® Original Article >

IRVINE, Calif., Sept. 16, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the partnership between actress and producer Malin Akerman and the Allergan Aesthetics body contouring portfolio. Akerman is named the first Allergan Aesthetics body contouring partner in support of both CoolSculpting®, the #1 nonsurgical fat reduction treatment used most by doctors, and CoolTone™, the latest treatment in the portfolio used to strengthen, tone, and firm the abdomen, buttocks, and thigh muscles.

“CoolSculpting® was a treatment I had been researching before this opportunity presented itself!” explains Malin Akerman. “I couldn’t pass up the opportunity to speak to experts in body contouring. For me, it was important to maintain the figure I have now, while shaping and contouring those trouble areas that have bugged me for quite some time now. Like any working woman, I have a lot to juggle daily. On top of that, I do my best to eat right and maintain an active and healthy lifestyle, but even so, I have some stubborn areas of fat just won’t budge and muscle groups I would like to tone and strengthen.”

Akerman worked with her doctor to devise a treatment plan custom to her unique body contouring goals.  Akerman was treated with CoolSculpting® to help reduce troublesome fat on her belly and flanks. She was also treated with CoolTone™ to help improve muscle tone and strength in her abdomen.

“People want non-surgical options to reduce fat and tone muscle. In fact, over 4 million people are considering noninvasive body contouring treatments within the next year1*,” says Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics. “We’re pleased to have Malin Akerman as the first U.S. ambassador for our body contouring portfolio to provide education and a first-hand look at the results that our proven treatments can provide.” 

As the U.S. ambassador, Akerman will be supporting the two new Allergan Aesthetics body contouring campaigns and encouraging consumers to take their body contouring goals further with CoolSculpting® and/or CoolTone™. Consumers have the opportunity to:

As part of her partnership with the brand, Akerman will appear in marketing materials, digital advertising and on CoolSculpting® social channels, as well as participate in public relations activities, where she will share her body contouring journey.

To learn more about the Allergan Aesthetic body contouring portfolio and to find a provider to see if CoolSculpting® and/or CoolTone™ may be right for you, please visit  

The safety and efficacy of CoolSculpting® and CoolTone™ in combination have not been evaluated by the FDA.

*Online survey of consumers (n=5,854) ages 18 to 74 with a BMI of 18.5 to 30.0 and an annual household income of $50,000 or more. Calculated from 2019 US census projections using 2018 data.

About Allergan Aesthetics

At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at Follow @abbvie on TwitterFacebookInstagramYouTube and LinkedIn.

Read Original Article >